SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-042621
Filing Date
2019-11-12
Accepted
2019-11-12 08:30:30
Documents
3
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stok-8k_20191104.htm 8-K 29920
2 EX-99.1 stok-ex991_6.htm EX-99.1 232361
3 GRAPHIC gwkvhbvaqrhe000001.jpg GRAPHIC 631
  Complete submission text file 0001564590-19-042621.txt   264497
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 191206349
SIC: 2834 Pharmaceutical Preparations